% Expired Patents = 50.0

EPO Patents = 2

Forward Citations = 78

Loading Chart...

8 inventors (with patents filed for the assignee):

David R Thomas (3 out of 28 patents)

Mark De Boer (3 out of 3 patents)

Pieter C J M Res (3 out of 3 patents)

4. Peter J Simons (2 out of 2 patents)

5. Antonino Cattaneo (1 out of 1 patent)

6. Sonia Covaceuszach (1 out of 1 patent)

7. Doriano Lamba (1 out of 1 patent)

8. Peter J Simone (1 out of 1 patent)

9. Robert Duncan Casson (1 patent)

10. Fiorenzo Stirpe (5 patents)

11. Andrea Bolognesi (2 patents)

12. Marcel Theodorus Den Hartog (0 patent)

13. Ruprecht Jules Joost Van Neerven (0 patent)

14. Kevin Stuart Johnson (0 patent)

4 patents: Sort by Forward Citations

1. 8296079 - Method for the humanization of antibodies and humanized antibodies thereby obtained (2012-10-23),

2. 7820807 - Gene constructs coding for CD40-binding activating antibodies (2010-10-26),

3. 7547438 - CD40-binding activating antibodies (2009-06-16),

4. 7172759 - Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies (2007-02-06),

Pangenetics B.V. is a leading biotechnology company specializing in the development of novel gene therapies for rare genetic diseases. Our innovative approach combines cutting-edge research with advanced technology to create targeted treatments that address the underlying causes of these conditions. With a strong focus on collaboration and innovation, we are dedicated to improving the lives of patients and families affected by rare genetic disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

4 Patents

#30 in Utrecht

#1,326 in Netherlands

Utrecht, Netherlands

Pangenetics B.v.